Rights and permissions
About this article
Cite this article
More control over drug use in HMOs, costs still rising. Pharmacoecon. Outcomes News 259, 5 (2000). https://doi.org/10.1007/BF03267052
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03267052